Total Payments
$44,838
2024 Payments
$11,115
Companies
92
Transactions
1,698
Medicare Patients
3,607
Medicare Billing
$801,627
Payment Breakdown by Category
Food & Beverage$32,901 (73.4%)
Other$9,035 (20.2%)
Travel$1,678 (3.7%)
Education$723.66 (1.6%)
Consulting$500.00 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $32,901 | 1,614 | 73.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,035 | 7 | 20.2% |
| Travel and Lodging | $1,678 | 3 | 3.7% |
| Education | $723.66 | 72 | 1.6% |
| Consulting Fee | $500.00 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $12,528 | 113 | $0 (2024) |
| ABBVIE INC. | $3,923 | 244 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,455 | 120 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,889 | 93 | $0 (2024) |
| Novo Nordisk Inc | $1,842 | 118 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $1,626 | 90 | $0 (2023) |
| PFIZER INC. | $1,619 | 87 | $0 (2024) |
| Lilly USA, LLC | $1,406 | 75 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,191 | 35 | $0 (2022) |
| Janssen Research & Development, LLC | $1,165 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,115 | 258 | Amgen Inc. ($6,606) |
| 2023 | $9,078 | 266 | Amgen Inc. ($4,311) |
| 2022 | $3,946 | 224 | ABBVIE INC. ($824.13) |
| 2021 | $3,875 | 205 | AbbVie Inc. ($652.37) |
| 2020 | $2,672 | 172 | Amgen Inc. ($373.31) |
| 2019 | $4,727 | 197 | Janssen Research & Development, LLC ($1,165) |
| 2018 | $3,928 | 164 | GlaxoSmithKline, LLC. ($563.04) |
| 2017 | $5,499 | 212 | SANOFI-AVENTIS U.S. LLC ($656.05) |
All Payment Transactions
1,698 individual payment records from CMS Open Payments — Page 1 of 68
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Inflammation | ||||||
| 11/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $23.78 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 640 | 1,758 | $411,520 | $150,777 |
| 2022 | 12 | 912 | 2,263 | $516,450 | $198,468 |
| 2021 | 18 | 1,004 | 2,752 | $677,065 | $239,113 |
| 2020 | 19 | 1,051 | 2,840 | $675,241 | $213,270 |
Total Patients
3,607
Total Services
9,613
Medicare Billing
$801,627
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 1,072 | $344,112 | $120,371 | 35.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $9,100 | $7,278 | 80.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 92 | 95 | $9,500 | $6,833 | 71.9% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 28 | 45 | $14,175 | $4,331 | 30.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 96 | 99 | $4,950 | $3,717 | 75.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $8,073 | $3,644 | 45.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 174 | $13,920 | $2,155 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,937 | $1,065 | 36.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,300 | $976.30 | 75.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 34 | $1,768 | $403.48 | 22.8% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 13 | 151 | $1,685 | $2.62 | 0.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 296 | 1,167 | $374,607 | $127,002 | 33.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 118 | 120 | $42,000 | $33,187 | 79.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 100 | 101 | $10,100 | $6,913 | 68.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 72 | $21,312 | $6,820 | 32.0% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2022 | 37 | 63 | $19,845 | $6,049 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $12,285 | $5,628 | 45.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 117 | 121 | $6,050 | $4,591 | 75.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 104 | 105 | $5,250 | $3,955 | 75.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 217 | $17,360 | $2,780 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 14 | $3,052 | $1,039 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 47 | $2,444 | $501.54 | 20.5% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2022 | 15 | 201 | $2,145 | $3.56 | 0.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 318 | 1,453 | $466,417 | $166,278 | 35.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 33 | 177 | $52,392 | $16,816 | 32.1% |
About Dr. David Cahn, MD
Dr. David Cahn, MD is a Specialist healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689762205.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Cahn, MD has received a total of $44,838 in payments from pharmaceutical and medical device companies, with $11,115 received in 2024. These payments were reported across 1,698 transactions from 92 companies. The most common payment nature is "Food and Beverage" ($32,901).
As a Medicare-enrolled provider, Cahn has provided services to 3,607 Medicare beneficiaries, totaling 9,613 services with total Medicare billing of $801,627. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location San Jose, CA
- Active Since 10/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689762205
Products in Payments
- Repatha (Biological) $10,395
- TRELEGY ELLIPTA (Drug) $1,740
- VRAYLAR (Drug) $1,565
- Livalo (Drug) $1,549
- ELIQUIS (Drug) $1,047
- Otezla (Drug) $946.50
- Ozempic (Drug) $898.06
- FARXIGA (Drug) $836.39
- TRULICITY (Drug) $735.03
- UBRELVY (Drug) $729.82
- QULIPTA (Drug) $659.64
- Aimovig (Biological) $650.12
- JARDIANCE (Drug) $644.39
- Trintellix (Drug) $597.65
- LINZESS (Drug) $587.59
- CAPLYTA (Drug) $526.11
- Synthroid (Drug) $513.01
- Yupelri (Drug) $442.38
- BELSOMRA (Drug) $431.93
- AREXVY (Drug) $345.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in San Jose
Dr. Andy Yu, M.d, M.D
Specialist — Payments: $70,866
Specialist $70,866
Dr. Randal Pham, M.d, M.D
Specialist — Payments: $18,018
Specialist $18,018
Dr. Vincent Lepore
Specialist — Payments: $14,397
Specialist $14,397
Dr. Xihua Sun, M.d. ,M.s, M.D. ,M.S
Specialist — Payments: $14,061
Specialist $14,061
Dr. Mitra Emami, M.d, M.D
Specialist — Payments: $12,922
Specialist $12,922
Dr. Sang Lee, M.d, M.D
Specialist — Payments: $8,154
Specialist $8,154